Nurse Anesthetist - CR in Jenks, OK Accepting Medicare

5 Nurse Anesthetist - CR nurses found. Showing 1 - 5

Andrew Mckinley Sledge, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3029 W Main St, Jenks, OK 74037 Phone: 918-701-2331    Fax: 918-417-7102

Dr. Frederick Das, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2020 W 109th St S, Jenks, OK 74037 Phone: 918-209-5532

Aaron Daniel Leddy, CRNA, DNP-A Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3029 W Main St, Jenks, OK 74037 Phone: 918-701-2300

Mackenzie Brubaker, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3029 W Main St, Jenks, OK 74037 Phone: 918-701-2300

Dr. Danielle Rae Macias, DNPA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3029 W Main St, Jenks, OK 74037 Phone: 918-701-2300

News Archive

IUPUI researchers find differing risks for binge drinking based on race, income and age

A new study led by Indiana University-Purdue University Indianapolis assistant professor of psychology Tamika Zapolski has found differing risks for binge drinking based on race, income and age.

New study reveals that moderate aerobic exercise improves insulin sensitivity in obese adolescents

A moderate aerobic exercise program, without weight loss, can improve insulin sensitivity in both lean and obese sedentary adolescents, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Insulin is a hormone produced in the pancreas that permits glucose to enter cells to be used for energy or stored for future use by the body.

Percentage of Americans without health coverage drops for 2nd year

The small decline was credited mainly to somewhat higher enrollments in Medicare and Medicaid, as well as the Children's Health Insurance Program.

USPTO issues patent to Tobira's cenicriviroc for treatment of HIV-1 infection

Tobira Therapeutics, Inc., developer of innovative antiretroviral therapies for HIV, today announced the United States Patent and Trademark Office has issued patent 8,183,273, claiming compositions of matter of a broad family of compounds with activity against chemokine receptors CCR5 and CCR2.

Read more Medical News

› Verified 1 days ago